Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN149,78149,840,67
Msft1,21
Nokia8,038,042-1,54
IBM-0,41
Mercedes-Benz Group AG46,9746,990,00
PFE1,08
11.08.2026 8:00:00
Indexy online
AD Index online
select
AD Index online
 

  • 10.08.2026
Plambck Neu Enrg (PNEGn.DE, Xetra)
Závěr k 10.8.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
9,89 -4,72 -0,49 508 562
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: PNE AG, formerly PNE Wind AG, is a Germany-based renewable energy company. The Company is operating as project developer in renewable energies. It operates through three segments such as project development, power generation and services. The project development segment plans and develops wind farms on land and at sea not only wind energy but also photovoltaics, green hydrogen and power-to-X technologies are also part of their offering. The service segment offers customers a comprehensive service portfolio and cover the entire spectrum from the planning to the operation of wind farms and photovoltaic projects as well as an all-round carefree package. The power generation provides electricity through onshore wind energy and photovoltaics with their own operations portfolio from project development.
Financial Summary: BRIEF: For the three months ended 31 March 2026, PNE AG revenues increased from EUR27.9M to EUR56.2M. Net loss applicable to common stockholders decreased 55% to EUR4.9M. Revenues reflect Project development segment increase from EUR3.6M to EUR18.6M, Power Generation segment increase of 49% to EUR29.3M, Consolidation segment increase from EUR0K to EUR2.7M. Lower net loss reflects Consolidation segment loss decrease of 94% to EUR1.5M.



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Member of the Executive CommitteeKarim Boussebaa-02.02.202602.02.2026
Deputy Chief Executive Officer, Senior Vice President - Development, Medical & Regulatory Affairs, Chief Pharmacist, Member of tPhilippe Bourrinet57
Group Chief Financial Officer, Senior Vice President - Business Development & Licensing, Member of the Executive CommitteeJerome Estampes-02.02.202601.01.2019
Senior Vice President - Commercial, Interventional Radiology, Member of the Executive CommitteeFrancois Convenant-19.12.202519.12.2025
Senior Vice President - Technical Operations, Member of the Executive CommitteeEric Kummer6114.10.202514.10.2025
Senior Vice President - Research, Development, Innovation and AI, Chief Digital Officer, Member of the Executive CommitteeFrancois Nicolas-
Senior Vice President - Diagnostic Imaging, Member of the Executive CommitteeValerie Brissart-
Director of Human Resources, Corporate Social Responsibility, Member of the Executive CommitteeEva Ohlsson-11.03.2024
Director - Public Affairs and Communications, Member of the Executive CommitteeChristine Allard-11.03.2024
Director - Legal Affairs, Member of the Executive CommitteeCharlotte Bamiere-06.04.2022